Skip to content

Helping adherence with glaucoma treatment: a randomised trial

A single centre randomised interventional trial of additional education and advice about glaucoma verus standard care in improving adherence with topical anti-glaucomatous therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89683704
Enrollment
200
Registered
2010-05-12
Start date
2009-11-23
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Eye, Primary Care Research Network for England

Interventions

The Education and Support intervention will be delivered by four GSAs using motivational interviewing techniques. Added 22/12/2010: Duration of follow-up is 8 months. Intervention not disclosed due

Sponsors

Norfolk and Norwich University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Added 22/12/2010: 1. Newly diagnosed or previously untreated glaucoma patients and ocular hypertension patients prescribed Travoprost 2. Over 18 years old, no upper age limit 3. Male and female

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Percentage adherence rate compared between control and intervention group. Added 22/12/2010: Outcome measures are recorded at 2 months and 8 months post-randomisation.

Secondary

MeasureTime frame
1. Correlate the level of self-reported adherence with actual adherence and determine associative factors 2. Identify the demand for specific components of the glaucoma support intervention 3. Identify predictors of the level of adherence Added 22/12/2010: Outcome measures are recorded at 2 months and 8 months post-randomisation.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026